Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.

World journal of gastroenterology - 21 Jun 2010

Zhou Guo-Wu, Hu Jia, Li Qiang

Abstract excerpt

AIM: To clarify the association between CYP2E1 PstI/RsaI polymorphism and susceptibility to colorectal cancer. METHODS: A meta-analysis based on 10 eligible case-control studies involving 4979 cases and 6012 controls was carried out to summarize the data on the association between CYP2E1 RsaI/PstI polymorphism and colorectal cancer risk. RESULTS: In comparison of the homozygote c2c2 and c2 carriers (c1c2 + c2c2)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Case-Control Studies
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2E1

Share to Deoxyribonucleases, Type II Site-Specific

Share to Homozygote

Share to Polymorphism, Restriction Fragment Length

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 20556843
DOI: 10.3748/wjg.v16.i23.2949
PMCID: PMC2887593

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.PMID 20556843Read ↗

CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis.Semantic proximity Read ↗

CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.Semantic proximity Read ↗

Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.Semantic proximity Read ↗

CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.Semantic proximity Read ↗

CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.Semantic proximity Read ↗

CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.Semantic proximity Read ↗

CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies.Semantic proximity Read ↗

CYP2E1 RsaI and 96-bp insertion genetic polymorphisms associated with risk for colorectal cancer.Semantic proximity Read ↗

Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.Semantic proximity Read ↗

CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.